Binding of platelet-activating factor to platelets of Alzheimer's disease and multiinfarct dementia patients

Neurobiology of Aging

Volumn 17, Issue 6, 1996, Pages 865-868

  Hershkowitz, Moshe ^a   Adunsky, Abraham ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

aging; Alzheimer; binding; cerebrovascular disease; platelet activating factor; platelets

Indexed keywords

THROMBOCYTE ACTIVATING FACTOR;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; KINETICS; MALE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; PROTEIN BINDING;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BLOOD PLATELETS; DEMENTIA, MULTI-INFARCT; FEMALE; HUMANS; KINETICS; MALE; MIDDLE AGED; NEUROBEHAVIORAL MANIFESTATIONS; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; SEX CHARACTERISTICS;

EID: 0030294866     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(96)00073-5     Document Type: Article

References (29)

1. 1. Adunsky, A.; Baram, D.; Hershkowitz, M.; Mekori, Y. A. Increased cytosolic free calcium in lymphocytes of Alzheimer patients. J. Neuroimmunol. 33:167-172; 1991.
2. 2. Aisen, P. S.; Davis, K. L. Inflammatory mechanisms in Alzheimer's disease: Implications for therapy. Am. J. Psychiatry 151:1105-1113; 1994.
3. 3. Bilenberg, G. W.; Wagener, G.; Beck, T. Infarct reduction by the platelet-activating factor antagonist Apafant in rats. Stroke 23:98-103; 1992.
4. 4. Blass, J. P.; Gibson, G. E. Nonneural markers in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 6:205-224; 1992.
5. 5. Chao, W.; Olson, M. S. Platelet-activating factor: Receptors and signal transduction. Biochem. J. 292:617-629; 1993.
6. 6. Feuerstein, G.; Yue, T.; Lysko, P. G. Platelet-activating factor a putative mediator in central nervous system injury? Stroke 21(Suppl. 3): 90-94; 1991.
7. 7. Folstein, M. F.; Folstein, S. E.; McHugh, P. R. Mini-mental state: A practical guide for grading the mental state of patients for the clinician. J. Psychiatr. Res. 12:189-198; 1975.
8. 8. Hachinski, V. C.; Iliff, L. D.; Zilkha, E.; du Boulay, G. H.; Macallister, V. L.; Marshall, J.; Ross Russell, R. W.; Symon, L. Cerebral blood flow in dementia. Arch. Neurol. 32:632-637; 1975.
9. 9. Hajimohammadreza, I.; Brammer, M. J.; Eagger, S.; Burns, A.; Levy, R. Platelet and erythrocyte membrane changes in Alzheimer's disease. Biochim. Biophys. Acta 1025:208-214; 1990.
10. 10. Hattory, M.; Adachi, H.; Tsujimoto, M.; Arai, H.; Inoue, K. Miller-Dicker lisencephaly gene encodes a subunit of brain platelet-activating factor. Nature 370:216-218; 1994.
11. 11. Hofferberth, B. The efficacy of EGb 761 in patients with senile dementia of the Alzheimer's type, a double-blind, placebo-controlled study on different levels of investigation. Hum. Psychopharmacol. 9:215-222; 1994.
12. 12. Hosford, D. J.; Domingo, M. T.; Chabrier, P. E.; Braquet, P. Ginkgolides and platelet-activating factor binding sites. Methods Enzymol. 18:433-446; 1990.
13. 13. Hwang, S. Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes. J. Biol. Chem. 263:3225-3233; 1988.
14. 14. Jiang, Z.; Yue, T.; Feuerstein, G. Platelet-activating factor inhibits excitatory transmission in rat neostriatum. Neurosci. Lett. 155:132-135; 1993.
15. 15. Kato, K.; Clark, G. D.; Bazan, N. G.; Zorumski, C. F. Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation. Nature 367:175-179; 1994.
16. 16. Kloprogge, E.; Akkerman, J. W. Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets. Biochem. J. 223:901-909; 1984.
17. 17. Kornecki, E.; Ehrlich, Y. H. Neuroregulatory and neuropathological action of the ether-phospholipid platelet-activating factor. Science 240:1792-1794; 1988.
18. 18. Marcheselli, V. L.; Rossowska, M. J.; Domingo, M.; Braquet, P.; Bazan, N. G. Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex. J. Biol. Chem. 265:9140-9145; 1990.
19. 19. Marcheselli, V. L.; Bazan, N. G. Platelet-activating factor is a messenger in the electroconvulsive shock-induced transcriptional activation of c-fos zif-268 in hippocampus. J. Neurosci. Res. 37:54-61; 1994.
20. 20. O'Brien, J. T.; Eager, S.; Syed, G. M. S.; Sahakian, B. J.; Levy, R. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 55:1182-1187; 1992.
21. 21. Pearlson, G. D.; Harris, G. J.; Powers, R. E.; Bark, P. E.; et al. Quantitative changes in mesial temporal volume, regional cerebral blood flow and cognition in Alzheimer's disease. Arch. Gen. Psychiatry 49:402-408; 1992.
22. 22. Prescott, S. M.; Zimmerman G. A.; McIntyre, T. M. Platelet-activating factor. J. Biol. Chem. 265:17381-17384; 1990.
23. 23. Rogers, J.; Kirby, L. C.; Hempelman, S. R.; Berry, D. L.; McGeer, P. L.; Kaszniak, A. W.; Zalinski, J.; et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology 43:1609-1611; 1993.
24. 24. Valone, F. H.; Coles, E.; Reinhold, V. R.; Goetzl, E. J. Specific binding of phospholipid platelet-activating factor by human platelets. J. Immunol. 129:1637-1641; 1982.
25. 25. Valone, F. H.; Goetzl, E. J. Specific binding by human polymorphonuclear leukocytes of the immunological mediator 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphorylcholine. Immunology 48: 141-149; 1983.
26. 26. Villardita, C. Alzheimer's disease compared with cerebrovascular dementia. Neuropsychological similarities and differences. Acta Neurol. Scand. 87:299-308; 1993.
27. 27. Wieraszko, A.; Li, G.; Kornecki, E.; Hogan, M.; Ehrlich, Y. H. Long-term potentiation in the hippocampus induced by platelet-activating factor. Neuron 10:553-557; 1993.
28. 28. Wilkinson, L. Systat: The system for statistics. Evanston, IL: Systat Inc.; 1988.
29. 29. Yue, T.; Feuerstein, G. Z. Platelet-activating factor: A putative neuromodulator and mediator in the pathophysiology of brain injury. Crit. Rev. Neurobiol. 8:11-24; 1994.